SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
ICF International intends to release its second quarter 2026 financial results on August 6, 2026. The company will host a webcast conference call at 4:30 p.m. Eastern to discuss pe…
Serina Therapeutics filed an amendment to its certificate of incorporation increasing authorized common shares to 125 million and preferred shares to 5 million. This increase provi…
JPMorgan Chase released hypothetical 2026 Dodd-Frank Act Stress Test results for a nine-quarter period under a restrictive economic scenario. The company noted the results reflect …
Elicio Therapeutics is disclosing the clinical roadmap for ELI-002 7P in metastatic pancreatic ductal adenocarcinoma. The company outlines the planned Phase 1 study evaluating comb…
Chewy entered into a Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The facility outlines the terms and structure for the company's loans and credit exten…
PIMCO Fund amended its prospectus to allow subprime and foreign loan investments, marking a significant strategic change.
The fund has amended its prospectus to permit direct lending and investment in subprime or unrated debt instruments, expanding its risk profile. This strategic shift increases pote…
The fund sold 961,171 common shares for $25.125 million via a private offering. This transaction highlights capital deployment efforts within the private credit sector.
PIMCO High Income Fund amended its prospectus to allow investments in subprime loans and increase common stock limits to 20%. These modifications expand the fund's risk tolerance a…
Micron Technology reported fiscal third quarter 2026 revenue of $41.46 billion and net income of $28.86 billion. The record results highlight the company's strong performance amids…
Indaptus Therapeutics entered into a definitive agreement to sell up to 20 million common shares at $0.60 per share, generating approximately $12 million. This private placement wi…
Wells Fargo Commercial Mortgage Securities entered a material definitive agreement on May 28, 2026, for the issuance of commercial mortgage debt. Investors monitor these CMBS trans…
Ionis Pharmaceuticals announced the FDA approval of olezarsen (Tryngolza), a new treatment for severe hypertriglyceridemia. This marks the company's first independent commercial la…
The registrant filed a Current Report on Form 8-K dated June 24, 2026. The text was truncated immediately upon the report of Item 8.01 Other Events, preventing identification of th…
Institutional holdings report (13F-HR) filed by Optimus Capital Advisors, LLC.
The Registrant entered into Transaction Documents related to the issuance of asset-backed securities by Ford Credit Auto Owner Trust 2026-B. This filing confirms the consummation o…
EFCAR transferred sub-prime automobile loan contracts to Exeter Automobile Receivables Trust 2026-3 in exchange for asset-backed notes worth $142M. The transaction illustrates a de…
Exeter Automobile Receivables Trust 2026-3 retained Morgan Lewis to advise on its Form SF-3 registration statement covering various transactions, with legal opinions attached as ex…
The Board of Trustees approved an amendment to the Fund's 80% investment policy effective August 28, 2026, allowing investments in non-corporate issuers. This change increases port…
PIMCO Corporate & Income Strategy Fund updated its 80% policy to allow flexible income-producing investments effective late August. This change intends to broaden the fund's invest…